02 December 2024
02 December 2024
The Optimize PRO clinical study was conducted across 50 global centres.
The subcutaneous ketamine-loaded implant is being developed as a treatment for fibromyalgia and chronic pain.
The BEST4 trial will consider the capsule sponge device for a future screening programme for Barrett’s oesophagus.
The signing ceremony was attended by EHA chairman Dr Ahmed El-Sebki and Roche Diagnostics general manager Dr Leila Kanaan.
The system leverages the company's deep learning technology and is claimed to potentially decrease scan times by up to 86%.
The device secured 510(k) clearance from the US Food and Drug Administration last year.
Albus Home was able to detect the early warning signs of asthma attacks in children up to five days before they occurred.
The global market for cardiovascular devices is projected to grow rapidly, with estimates of $140 billion by 2033.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
